FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Triamcinolone Acetonide | .6 mg/.6 mL; 9 mg/.6 mL | 2024-1 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate | 1 mg/1 mL; 10 mg/1 mL | 2024-1 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2024-1 | source_no_ndc | 2026-11-08 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2024-1 | source_no_ndc | 2026-11-08 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0012 | 71139-0012-1 | Oxytocin | 30 U/500 mL | 2024-1 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-7084 | 71139-7084-1 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2024-1 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5340 | 71139-5340-1 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/200 mL; 400 ug/200 mL | 2024-1 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5340 | 71139-5340-2 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/200 mL; 400 ug/200 mL | 2024-1 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0190 | 71139-0190-1 | "vasopressin, Unspecified" | 2 U/2 mL | 2024-1 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5330 | 71139-5330-2 | Cefazolin Sodium | 3 g/30 mL | 2024-1 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-7087 | 71139-7087-1 | Cefazolin Sodium | 2 g/20 mL | 2024-1 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5350 | 71139-5350-1 | Epinephrine; Bupivacaine Hydrochloride | 150 ug/30 mL; 150 mg/30 mL | 2024-1 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-5345 | 71139-5345-2 | Epinephrine; Bupivacaine Hydrochloride | 150 ug/30 mL; 75 mg/30 mL | 2024-1 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-6030 | 71139-6030-1 | Fentanyl Citrate | 2500 ug/50 mL | 2024-1 | valid | 2026-11-08 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0018 | 71139-0018-1 | Hydromorphone Hydrochloride | 20 mg/100 mL | 2024-1 | valid | 2026-11-08 | ||
| "McGuff Pharmaceuticals, Inc. DBA McGuff Outsourcing Solutions(134632103)" | 67157-005 | 67157-005-30 | Procaine; Sodium Metabisulfite | 20 mg/30 mL; / | 2024-1 | valid | 2026-11-08 | ||
| "McGuff Pharmaceuticals, Inc. DBA McGuff Outsourcing Solutions(134632103)" | 67157-135 | 67157-135-30 | Glutathione | 200 mg/30 mL | 2024-1 | valid | 2026-11-08 | ||
| "McGuff Pharmaceuticals, Inc. DBA McGuff Outsourcing Solutions(134632103)" | 67157-001 | 67157-001-30 | Methionine | 25 mg/30 mL | 2024-1 | valid | 2026-11-08 | ||
| "McGuff Pharmaceuticals, Inc. DBA McGuff Outsourcing Solutions(134632103)" | 67157-006 | 67157-006-30 | Methylcobalamin | 30 mg | 2024-1 | valid | 2026-11-08 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-957 | 69374-957-10 | Phenylephrine Hydrochloride | 100 ug/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-924 | 69374-924-05 | Rocuronium Bromide | 10 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-984 | 69374-984-10 | Sodium Bicarbonate; Lidocaine Hydrochloride; Potassium Chloride | 1.04 g/1 mL; 123 mg/1 mL; 2.19 g/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-919 | 69374-919-10 | Succinylcholine Chloride | 20 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-330 | 69374-330-05 | Albuterol | 5 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-982 | 69374-982-55 | Ketamine Hydrochloride | 30 mg/3 mL | 2024-1 | valid | 2026-11-08 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-988 | 69374-988-10 | Lysine Hydrochloride; Arginine Hydrochloride | 5000 g/1 mL; 5000 g/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9057 | 83826-9057-2 | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9055 | 83826-9055-5 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 10 mg/1 mL; .75 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9033 | 83826-9033-5 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 10 mg/1 mL; 5 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9018 | 83826-9018-5 | Bimatoprost; Timolol Maleate | .1 mg/1 mL; 5 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9003 | 83826-9003-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine Tartrate | .1 mg/1 mL; 5 mg/1 mL; 20 mg/1 mL; 1 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9006 | 83826-9006-5 | Timolol Maleate; Brimonidine Tartrate; Dorzolamide Hydrochloride | 5 mg/1 mL; 1 mg/1 mL; 20 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9059 | 83826-9059-2 | Dorzolamide Hydrochloride; Brimonidine Tartrate | 20 mg/1 mL; 1 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9010 | 83826-9010-3 | Atropine Sulfate | .1 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9011 | 83826-9011-3 | Atropine Sulfate | .25 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9012 | 83826-9012-3 | Atropine Sulfate | .5 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9034 | 83826-9034-5 | Moxifloxacin Hydrochloride; Bromfenac Sodium | 10 mg/1 mL; 75 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9004 | 83826-9004-1 | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 5 mg/1 mL; 1 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9017 | 83826-9017-8 | Moxifloxacin Hydrochloride; Ketorolac Tromethamine; Prednisolone Sodium Phosphate | 5 mg/1 mL; 5 mg/1 mL; 10 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9016 | 83826-9016-8 | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 5 mg/1 mL; 10 mg/1 mL; .75 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "OSRX, Inc.(117108300)" | 83826-9014 | 83826-9014-5 | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 5 mg/1 mL; 10 mg/1 mL; .75 mg/1 mL | 2024-1 | valid | 2026-11-08 | ||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 16 mg/250 mL | 2024-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2024-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 16 mg/250 mL | 2024-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 16 mg/250 mL | 2024-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 2 g/2 L | 2024-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2024-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 3 g/3 L | 2024-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 8 mg/250 mL | 2024-1 | source_no_ndc | 2026-11-08 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 30 U/500 mL | 2024-1 | source_no_ndc | 2026-11-08 |